Laval – In June 2022, the Government of Canada established a long-term agreement with Moderna for the domestic production of messenger RNA (mRNA) vaccines in Canada. The negotiations began in 2021, during the depths of the COVID-19 pandemic, as the country faced intense global competition to secure vaccines. This global supply chain vulnerability showcased the need to ensure domestic capacity …